In this Spanish language audio recording, Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss PDL1 as a biomarker for first-line treatment.
Sara was diagnosed with stage IV RET+ lung cancer in 2010. Traditional chemo and radiation followed with great success. In the years since Sara has been on and off treatment several times. She is currently taking nivolumab and doing very well. Sara lives in Dayton, OH with her husband, JD, and two daughters Katie and Elena. Katie just headed off to college at Washington University in St. Louis while Elena is in the 10th grade.
Vamsidhar Velcheti, MD, is a staff Physician of Medicine at the Cleveland Clinic Lerner College of Medicine and staff physician in the Department of Hematology and Oncology at Cleveland Clinic Taussig Cancer Institute. His specialty areas include lung cancer, mesothelioma, and thymic tumors and the use of novel immunotherapies for the treatment of lung cancer. Dr.
James P. Stevenson, MD, is currently a Staff Physician at the Cleveland Clinic where he serves as Vice-Chairman of the Taussig Cancer Institute Department of Hematology and Oncology.
Kathryn Sefcek, MHA has been at the Cleveland Clinic for 6 years and currently serves as a 4th Angel Program Coordinator at the Taussig Cancer Institute managing the day-to-day operations of the 4th Angel Mentoring Program, a patient/survivor, and caregiver support program. Kathryn possesses over 15 years of experience in healthcare coupled with a Master’s Degree in Health Administration from Ohio University and Bachelor’s Degree in Social Work from the University of Akron. Ms.
A GLOBAL RESOURCE FOR ADVANCING CANCER EDUCATION
Up-to-date news and information from cancer experts and doctors all over the globe. Whether you’re a doctor, patient or caretaker, we have the information to power you forward. LEARN MORE
In this Spanish language audio recording, Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss combinations for first-line treatment - immunotherapy combined.
Dr. Luis Raez, MD FACP FCCP joined GRACE to discuss combinations for first-line treatment - immunotherapy with chemotherapy.
Welcome to the Global Resource for Advancing Cancer Education
Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses new options in acquired resistance for ALK positive non-small cell lung cancer (NSCLC).